经皮肝穿刺胆管引流术联合支架植入术治疗恶性梗阻性黄疸.pdf

《经皮肝穿刺胆管引流术联合支架植入术治疗恶性梗阻性黄疸.pdf》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、中国介入影像与治疗学2012年第9卷第5期ChinJIntervImagingTher，2012，Vol9，No5·327·PercutaneoustranshepaticbiledrainageandpercutaneoustranshepaticcholangialstentingintreatmentofmalignantobstructivejaundiceLUOXiao—ning，L己，L—gong“，SHAOPei-jian，H【，Bao—shan。，LYong(1．CollegeofPostgrad

2、uate，SouthernMedicalUniversity，Guangzhou510000，China；2．DepartmentofInterventionalRadiology，GuangdongAcademyofMedicalSciences，GuangdongGeneralHospital，Guangzhou510080，China)~Abstract]ObjectiveToevaluatetheshort—-termandlong—-termclinicalefficacyofpercutaneoust

3、ranshepaticbiledrainage(PTBD)andPTBD+percutaneoustranshepaticcholangialstent(PTCS)inthetreatmentofmalignantobstructivejaun—dice．MethodsSixtypatientsofmalignantobstructivejaundiceunderwentinterventionaltherapy，ofwhich30underwentPTBD+PTCS(groupA)，andtheother30u

4、nderwentonlyPTBD(groupB)．Thetotalbilirubin(TBIL)，directbilirubin(DB1L)，complications，patencyperiodandthesurvivaltimeafterinterventionwereanalyzed．ResultsOneweekaftertreatment．TBILdecreasedby(174．81士49．13)~mot／L，(95．23士42．33)~mol／LingroupAandB，respectively(P一0

5、．02)，whileDBILdecreasedby(96．01士36．51)pmol／Land(58．16±31．21)／zmol／L，respectively(P一0．03)．Omemonthaftertreatment，TBILdecreasedby(284．25士112．53)~mol／Land(276．42±125．47)~tmol／LingroupAandB，re—spectively(P一0．09)，whileDBILdecreasedby(152．06±41．32)~．mol／Land(147．06

6、士43．83)／~mol／L，respectively(P一0．13)．Theoverallincidencerateofcomplicationswas36．67(11／30)ingroupA，significantlylowerthanthatingroupB(27／30，90．O0)，andthedifferencewasstatisticallydifferent(一18．37，P

7、pswere162．5vs78．5daysand203．5vs126．0days(bothP

8、ndice，obstructive；Drainage；Stents经皮肝穿刺胆管引流术联合支架植入术治疗恶性梗阻性黄疸罗小宁，陆骊工，邵培坚。，胡宝山。，李勇(1．南方医科大学研究生学院，广东广州510000；2．广东省医学科学院广东省人民医院肿瘤介入科，广东广州510080)[摘要]目的评价经皮肝穿刺胆管引流术(PTBD)联合支架植入术与单纯PTBD姑息治疗恶性梗阻性黄